Luye Pharma boosts convertible to $300m

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Luye Pharma boosts convertible to $300m

Jonathan Breen
June 25, 2019 11:15 AM
Pills_medicine_230px

Hong Kong-listed Luye Pharma Group sealed a convertible bond on Monday night, raising $300m from the increased deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

UBSEquityChinaHong Kong SARAsiaGreater ChinaNortheast AsiaAsia PacificEmerging MarketsSRIGoldman SachsEquity-Linked
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article